June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Angiotensin II infusion induces high blood pressure and decrease in tear secretion.
Author Affiliations & Notes
  • Shigeru Nakamura
    Ophtalmology, Kei University, Tokyo, Japan
  • Ryuji Hisamura
    Ophtalmology, Kei University, Tokyo, Japan
  • Toshihiro Imada
    Ophtalmology, Kei University, Tokyo, Japan
  • Yusuke Izuta
    Ophtalmology, Kei University, Tokyo, Japan
  • Kazuo Tsubota
    Ophtalmology, Kei University, Tokyo, Japan
  • Footnotes
    Commercial Relationships Shigeru Nakamura, Ophtecs (E); Ryuji Hisamura, None; Toshihiro Imada, None; Yusuke Izuta, None; Kazuo Tsubota, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2493. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shigeru Nakamura, Ryuji Hisamura, Toshihiro Imada, Yusuke Izuta, Kazuo Tsubota; Angiotensin II infusion induces high blood pressure and decrease in tear secretion.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2493.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The systemic renin-angiotensin system (RAS) plays an important role in the endocrine regulation of blood pressure and of salt and water balance. Tissue-specific RAS is present in the lacrimal gland and might be involved in tissue function of regulating tear secretion in the lacrimal gland. The purpose of this study was to investigate the effect of angiotensin II (Ang II) on tear secretion.

Methods: Female C57BL/6 mice at an age of 8 weeks were used in this study. Mice were anesthetized by pentobarbital, and an osmotic minipump (Alzet model 2004) was implanted to deliver Ang II subcutaneously at a dose of 1.5 mg/kg/day for 4 weeks. Systolic blood pressure was measured with an automated tail-cuff device. Change in tear secretion was measured by the cotton thread test for 15 seconds. After Ang II treatment, the mice were killed by cervical dislocation. The lacrimal glands were removed for histological examination.

Results: A significant difference was not observed in body weight gain among Ang II treatment and vehicle groups. Through the treatment period, a significant increase in systolic blood pressure we observed in Ang II treatment group (116 ± 0.55 vs 140 ± 31, P<0.001 vs vehicle, n=5, day 14). Tear secretion was lower in the Ang II treatment group than the initial value through the treatment period and significant decrease were observed compared to the vehicle group from day 3 to day14 (3.06 ± 0.88 vs 2.21 ± 0.45, P<0.001 vs vehicle, n=5, day 14). Reduction of lacrimal achiner cell area were apparent in the Ang II treatment group.

Conclusions: These data suggest that activation of angiotensin receptor by Ang II reduces tear secretion and RAS play an important role in regulation of tear secretion.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×